US weight-loss drugs may save major airlines $580M annually in fuel costs

According to The New York Times, reduced passenger weight due to the use of GLP-1 receptor agonist drugs, including Ozempic, could lower fuel expenses for American Airlines, Delta Air Lines, Southwest Airlines, and United Airlines by 1.5%, increasing earnings per share by 4%.